Company intelligence / Profile preview

Pangaea Ventures

Vancouver, British Columbia, Canada

Ownership: Private
Development stage: Other

Overview

Pangaea Ventures is a leading venture capital firm founded in 2000 that specializes in investing in hard tech startups leveraging advanced materials, chemistry, and biology. The firm focuses on supporting innovations that address global challenges related to planetary health—including clean energy, sustainable agriculture, and next-generation therapeutics—by backing early-stage ventures with transformative potential. Its investments span sectors from bioprinted tissue therapeutics to microbiome-based immuno-oncology drugs through its diverse portfolio of over 40 active ventures across North America and beyond.

Industry: Investors

Partnerships

Foothill Ventures (co-investor)In-Q-Tel (co-investor)Intel Capital (co-investor)Novo Nordisk’s venture arm M Ventures (co-investor)

Beyond the preview

Go deeper on Pangaea Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pangaea Ventures.

Explore the full profile